Quest Diagnostics Incorporated
Quest Diagnostics Incorporated (DGX) Revenue
Annual & quarterly revenue history · segment & region breakdown
DGX · revenue · updated Jun 8, 2026
Core revenue metrics
Trailing 12 monthsQuest Diagnostics Incorporated trailing twelve-month (TTM) revenue is $11.28B, an increase of 11.78% year-over-year from $11.04B in FY2025.
Revenue trend
2025 – 2006 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-12-31 | $11.04B | +$1.16B | +11.78% |
| 2024-12-31 | $9.87B | +$0.62B | +6.70% |
| 2023-12-31 | $9.25B | -$0.63B | -6.38% |
| 2022-12-31 | $9.88B | -$0.91B | -8.39% |
| 2021-12-31 | $10.79B | +$1.35B | +14.32% |
| 2020-12-31 | $9.44B | +$1.71B | +22.15% |
| 2019-12-31 | $7.73B | +$0.20B | +2.59% |
| 2018-12-31 | $7.53B | -$0.18B | -2.31% |
| 2017-12-31 | $7.71B | +$0.19B | +2.58% |
| 2016-12-31 | $7.51B | +$0.02B | +0.29% |
Compare revenue vs peers
Medical - Diagnostics & ResearchCompare DGX revenue against listed peers. Click any row to open that company's revenue tab.
Revenue breakdown
Segment & GeographyAbout Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Quest Diagnostics Incorporated receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Quest Diagnostics Incorporated reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Quest Diagnostics Incorporated's 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
DGX revenue · 4 questionsDGX's trailing twelve-month (TTM) revenue is $11.28B. That is an increase of 11.78% year-over-year from $11.04B in FY2025.
▸ Source: FMP · Quest Diagnostics Incorporated SEC filings · GAAP · Quest Diagnostics Incorporated SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026